The South Korean conglomerate plans to increase investments by a third to more than $205 billion over the next three years, as it races for leadership in chip making and a bigger role in Covid-19 vaccine production.
Read More
The South Korean conglomerate plans to increase investments by a third to more than $205 billion over the next three years, as it races for leadership in chip making and a bigger role in Covid-19 vaccine production.
Read More